CAS: 30838-93-8; 2-Chloro-4,6-Dimethylpyridine

相似化合物

1824165-57-2 25462-98-0 18368-63-3

上下游产品

CAS号5407-87-4 2-氨基-4,6-二甲基吡啶 | CAS号915946-47-3 3,5-dibromo-2-c... | CAS号98-80-6 苯硼酸 | CAS号857429-63-1 3,5-dibromo-4,6... | CAS号16115-08-5 4,6-二甲基-2-羟基吡啶 | CAS号10026-13-8 五氯化磷 | CAS号324028-95-7 6-氯-4-甲基吡啶-2-羧酸 | CAS号108-47-4 2,4-二甲基吡啶 | CAS号25462-85-5 2-氯-6-甲基异烟酸 | CAS号163613-83-0 Piperazine, 1-(...

4,6-二甲基-2-羟基吡啶置于四(三苯基膦)钯 溴,Sodium Carbonate,溶剂黄146,三氯氧磷体系中,用 乙醇,水,甲苯 用作溶剂,化学反应 17.0H,反应生成2-氯-4,6-二甲基吡啶
参考文献:A Suzuki-Miyaura Approach To A Series Of Forensically Relevant Pyridines
标题:A Suzuki-Miyaura Approach To A Series Of Forensically Relevant Pyridines
摘要:本文介绍了制备十六种具有重要法医意义的 3,5 二取代 2,4-和 2,6 二甲基吡啶的简便通用方法.一系列环取代的苯硼酸与 3,5-二溴-2,4-二甲基吡啶和 3,5-二溴-2,6-二甲基吡啶之间的铃木交叉偶联反应被用作关键步骤.
Doi:10.1055/s-2006-942535

专利信息

专利号:US-2023399302-A1
优先权日:2020-10-29
标题:Process for the preparation of heteroaryl-substituted sulfur(vi) compounds
发明人：LOPCHUK JUSTIN M; SHULTZ ZACHARY P; SCATTOLIN THOMAS
权利人:H LEE MOFFITT CANCER CT & RES
摘要:The present disclosure provides processes for the synthesis of organic compounds, in particular processes for the synthesis of heteroaryl-substituted sulfur(VI) compounds by nucleophilic aromatic substitution.

专利号:US-2022081413-A1
优先权日:2020-08-12
标 题 :Synthesis of quinazoline compounds

专利号:US-9663511-B2
优先权日:2012-03-26
标题:Sphingosine 1-phosphate receptor antagonists
发明人：SWENSON ROLF E
权利人:ARROYO BIOSCIENCES LLC
摘要:The present invention relates to sphingosine-1-phosphate (S1P) receptors and compounds of the general formula: n nthat are useful in the treatment and prevention of conditions associated with such receptors. More specifically, the present invention relates to the synthesis and use of sphingosine 1-phosphate receptor 2 (S1P 2 ) antagonists that are useful in the treatment of cancer, atherosclerosis, diabetic retinopathy, and other inflammatory diseases. Among these inflammatory diseases that could be treated with these S1P 2 antagonist are those characterized by fibrosis including chronic lung disease, chronic kidney and liver disease, chronic heart disease, and skin diseases such as sclerosis/scleroderma. The S1P 2 antagonists can also be used in the treatment of glioblastoma multiforme (brain cancer), pediatric neuroblastoma, and other cancers.